Подписаться
Shreyas Gaikwad
Shreyas Gaikwad
Research Scientist, SynVivo Inc.
Подтвержден адрес электронной почты в домене synvivobio.com
Название
Процитировано
Процитировано
Год
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
S Gaikwad, MY Agrawal, I Kaushik, S Ramachandran, SK Srivastava
Seminars in cancer biology 86, 137-150, 2022
1222022
The evolutionary legacy of immune checkpoint inhibitors
I Kaushik, S Ramachandran, C Zabel, S Gaikwad, SK Srivastava
Seminars in cancer biology 86, 491-498, 2022
642022
Role of phytochemicals in perturbation of redox homeostasis in cancer
S Gaikwad, SK Srivastava
Antioxidants 10 (1), 83, 2021
422021
Atovaquone suppresses triple-negative breast tumor growth by reducing immune-suppressive cells
N Gupta, S Gaikwad, I Kaushik, SE Wright, MM Markiewski, SK Srivastava
International Journal of Molecular Sciences 22 (10), 5150, 2021
312021
Handbook of oxidative stress in cancer: therapeutic aspects
S Chakraborti
Springer Nature, 2022
162022
Interferon stimulated gene 15 (ISG15) in cancer: An update
HM Nguyen, S Gaikwad, M Oladejo, MY Agrawal, SK Srivastava, ...
Cancer Letters 556, 216080, 2023
152023
Targeting ubiquitin-like protein, isg15, as a novel tumor associated antigen in colorectal cancer
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, LM Wood
Cancers 15 (4), 1237, 2023
92023
Antioxidant Activity of Phytochemicals in Cancer
SR Gaikwad, SK Srivastava
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects https://doi.org …, 2022
72022
Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics
MY Agrawal, S Gaikwad, S Srivastava, SK Srivastava
Cancers 14 (22), 5482, 2022
52022
Exploring the significance of extracellular vesicles: Key players in advancing cancer and possible theranostic tools
B Patel, S Gaikwad, S Prasad
Cancer Pathogenesis and Therapy 2, E01-E44, 2024
12024
Deciphering CD59: Unveiling Its Role in Immune Microenvironment and Prognostic Significance
B Patel, A Silwal, MA Eltokhy, S Gaikwad, M Curcic, J Patel, S Prasad
Cancers 16 (21), 3699, 2024
2024
Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy
S Gaikwad, SK Srivastava
Molecular Therapy 32 (9), 3145-3162, 2024
2024
Abstract LB267: Disrupting cytoplasmic proton motive force induces ferroptotic cell death in colorectal cancer: A novel anti-cancer mechanism
SR Gaikwad, MA Eltokhy, M Moore, K Kailath, SK Srivastava
Cancer Research 84 (7_Supplement), LB267-LB267, 2024
2024
MBO enhances anti-tumor immunity in pancreatic ductal adenocarcinoma by inducing immunogenic apoptosis
SR Gaikwad, SK Srivastava
Cancer Research 84 (6_Supplement), 5262-5262, 2024
2024
New generation drug development from in-silico identification to preclinical evaluation in glioblastoma
M Arunachalam, S Gaikwad, S Ramachandran, SK Srivastava
Cancer Research 84 (6_Supplement), 3503-3503, 2024
2024
Targeting the β-catenin signaling axis in osteosarcoma
M Curcic, S Gaikwad, SK Srivastava
Cancer Research 84 (6_Supplement), 7156-7156, 2024
2024
Vitro bioprinted tumor models and bioinks for solid tumor bioprinting
SK Srivastava, S Gaikwad
US Patent App. 18/126,214, 2023
2023
Abstract LB201: A novel combination of Listeria-based immunotherapy and repurposed drug combats colorectal cancer
SR Gaikwad, HM Nguyen, SK Srivastava, L Wood
Cancer Research 83 (8_Supplement), LB201-LB201, 2023
2023
Novel 3D bioprinted pancreatic tumor models for anti-cancer drug assessment
SR Gaikwad, SK Srivastava
Cancer Research 83 (7_Supplement), 197-197, 2023
2023
A novel drug suppresses pancreatic cancer growth through immunomodulation
SR Gaikwad, SK Srivastava
Cancer Research 83 (7_Supplement), 580-580, 2023
2023
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20